Amherst, NY, United States of America

Cheng-Der Yu


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1993-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cheng-Der Yu: Innovator in Transdermal Delivery Systems

Introduction

Cheng-Der Yu is a notable inventor based in Amherst, NY (US). He has made significant contributions to the field of transdermal drug delivery, holding 2 patents that showcase his innovative approaches to therapeutic administration.

Latest Patents

One of his latest patents is focused on the "Iontophoretic transdermal delivery of deoxyspergualin compounds." This patent describes a method and system for the noninvasive administration of a therapeutic concentration of a deoxyspergualin compound to a patient. The process involves iontophoretically passing the deoxyspergualin compound through an area of the skin at a flux effective to provide the desired therapeutic concentration. Another significant patent is for "Topical anti-fungal agents having anti-inflammatory activity." This patent reveals that certain imidazoles exhibit both anti-inflammatory and antifungal properties, expanding the potential applications of these compounds in medical treatments.

Career Highlights

Cheng-Der Yu is currently associated with Bristol-Myers Squibb Company, where he continues to work on innovative solutions in drug delivery. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Throughout his career, Cheng-Der Yu has collaborated with esteemed colleagues, including Hemanshu S Shah and Mark A Tepper. These collaborations have further enriched his research and development efforts, leading to advancements in therapeutic technologies.

Conclusion

Cheng-Der Yu's contributions to transdermal delivery systems highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical technology and enhancing therapeutic efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…